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 CAPSULE SUMMARY 79 
 80 
- Inpatient access to dermatologists is limited, highlighting an opportunity to utilize 81 
teledermatology within the inpatient setting.  82 
- Teledermatology in the inpatient setting may be a clinically acceptable option for 83 
diagnosis, evaluation, and management. This may represent a novel and effective option 84 
for hospitals.  85 
 86 
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 ABSTRACT: 120 
 121 
Background: Patient outcomes are improved when dermatologists provide inpatient consults. 122 
Inpatient access to dermatologists is limited, illustrating an opportunity to utilize 123 
teledermatology. Little is known about the ability of dermatologists to accurately diagnose and 124 
manage inpatients using teledermatology, particularly utilizing non-dermatologist generated 125 
clinical data. 126 
Methods: This prospective study assessed the ability of teledermatology to diagnose and manage 127 
41 dermatology consults from a large urban tertiary care center utilizing internal medicine 128 
referral documentation and photos. Twenty-seven dermatology hospitalists were surveyed. 129 
Interrater agreement was assessed by the kappa statistic.  130 
Results: There was substantial agreement between in-person and teledermatology assessment of 131 
the diagnosis with differential diagnosis (median kappa = 0.83), substantial agreement in 132 
laboratory work-up decisions (median kappa = 0.67), almost perfect agreement in imaging 133 
decisions (median kappa = 1.0), and moderate agreement in biopsy decisions (median kappa = 134 
0.43). There was almost perfect agreement in treatment (median kappa = 1.0), but no agreement 135 
in follow-up planning (median kappa = 0.0). There was no association between raw photo quality 136 
and the primary plus differential diagnosis or primary diagnosis alone.  137 
Limitations: Selection bias and single-center nature. 138 
Conclusions: Teledermatology may be effective in the inpatient setting, with concordant 139 
diagnosis, evaluation, and management decisions. 140 
 141 
 142 
 143 
 BACKGROUND: 144 
Teledermatology is the remote dermatologic assessment of patients, in real-time (“live 145 
interactive”), by accessing stored data (“store-and-forward”), or a combination of the two 146 
(“hybrid”), with worldwide applications.(1) Teledermatology has been studied in general triage, 147 
consultation in remote locations, and monitoring of chronic skin conditions.(1) In addition to 148 
increased access to dermatologists, potential benefits of store-and-forward teledermatology 149 
include cost reduction due to fewer face-to-face (FTF) consultations,(2) reduced travel time and 150 
opportunity cost due to missed work,(3-5) and reduced contagion spread amid infectious disease 151 
outbreaks.  152 
Significant clinical evidence supports the outpatient use of store-and-forward 153 
teledermatology.(2-10) In contrast, teledermatology has been studied in the inpatient setting to a 154 
limited degree. A significant practice gap exists between the demand for inpatient dermatology 155 
services and access to dermatologists,(11, 12) often a source of frustration for inpatient providers 156 
and patients. Dermatology hospitalists represent a clinical group with expertise in complex 157 
medical dermatology and the diagnosis and management of skin diseases affecting hospitalized 158 
patients. Involvement of dermatology hospitalists in the care of hospitalized patients has been 159 
found to improve patient outcomes.(13) In a subset of cases, inpatient teledermatology reduces 160 
time for the primary medical team to receive a response for a dermatology consultation.(14)  161 
Dermatologist interest in inpatient teledermatology is high. A survey of attending dermatologists 162 
demonstrated that 61.5% agreed or strongly agreed that teledermatology helps inpatient care.(15) 163 
Another study found that 95% of hospital and emergency department practitioners would utilize 164 
a teledermatology consult service if available, however only 5% believed that teledermatology 165 
would be equivalent to a face-to-face (FTF) consult.(16) This finding supports the need for 166 
 additional studies evaluating inpatient teledermatology, which may shift perception and 167 
encourage adoption of inpatient teledermatology. 168 
This study investigates the diagnostic and management agreement between inpatient FTF and 169 
store-and-forward teledermatology evaluations utilizing remote digital evaluations for hospital-170 
based dermatology consultations. 171 
METHODS 172 
 173 
Eligible patients for this study were admitted to Massachusetts General Hospital between July 174 
and August 2013 and had a dermatology consultation staffed by a dermatology hospitalist with 175 
more than six years of inpatient experience, defined as the Primary Dermatologist (PD). This 176 
yielded a sample of 108 patients. Only those consultations with digital images and non-177 
dermatology evaluations involving the dermatologic complaint were included. Cases were 178 
selected if the accuracy of the PD’s diagnosis was able to be confirmed based on testing, 179 
response to therapy and final diagnosis at discharge. Based on these inclusion criteria, a total of 180 
42 patients were initially included (Figure 1). One case was excluded from analysis to preserve 181 
the generalizability of study results,(17) as this patient presented with multiple concomitant 182 
dermatologic complaints and the documentation did not specify the specific focus of the 183 
dermatology consultation. 184 
For teledermatology review, data abstractors not involved in the care of the included cases 185 
packaged patient data into surveys by unique numerical patient identifiers. Each survey set 186 
contained seven individual cases, randomly assigned to each survey set from the total case pool. 187 
Each individual case contained the relevant history and physical exam notes generated by a non-188 
dermatologic internal medicine or emergency medicine provider. In addition, all data such as 189 
laboratory studies, imaging, microbiology, pathology, and digital images up to the day of the 190 
 consult that would have been available to the PD were included. Finally, a 191 
diagnosis/management questionnaire was included. The order of case examination within each 192 
survey set was fixed across all TDs. Patient identifiers were uniquely created and stored safely. 193 
This study was approved by Partners Institutional Review Board (IRB) #2018P002762. 194 
Only non-dermatologic patient history and physical exam notes were included to mimic real-195 
world settings. Photographs were captured primarily by Dermatology Residents from the 196 
Harvard Combined Dermatology Residency. Camera use was heterogenous and included Sony 197 
NEX5N 12MP and 5MP iPad Mini. Images were obtained both by using the original digital 198 
images and screengrabs from the electronic medical record. Study data were collected and 199 
managed using Research Electronic Data Capture (REDCap) tools hosted at Partners.(18, 19) 200 
The packaged cases were sent to 27 experienced dermatology hospitalists in order of response to 201 
request for participation at various academic institutions across the U.S. Each remote 202 
teledermatologist (TD) received six to seven cases within a secure REDCap survey 203 
(Supplemental Figure 1). Each clinical case was evaluated by 4-5 unique TDs.  204 
The surveys included the option to list a primary diagnosis as well as a maximum of three 205 
differential diagnoses. The workup and management plans offered were as follows: (1) biopsy, 206 
(2) topical therapy, (3) systemic/oral therapy, (4) microbiology, (5) labs, (6) transfer to the burn 207 
unit, if not already there, (6) recommend continued patient monitoring as an inpatient, and (7) 208 
recommend follow-up as outpatient for dermatologic condition. Once the TD selected a 209 
treatment plan, s/he was prompted for free-text details. Both the correct mode and type of 210 
therapy was assessed. If the selected treatment differed between the PD and the TD but both 211 
options were within the accepted standard of care for that disease, these treatments were 212 
 considered concordant. This was to minimize the effect of stylistic practice differences in 213 
grading appropriateness. 214 
The follow-up plan options were: (1) sign-off and no need for future follow-up either inpatient or 215 
outpatient, (2) outpatient follow-up, no need for additional inpatient dermatology evaluations 216 
(“sign off”), (3) no need to see the patient tomorrow, but evaluate if the primary team requests 217 
and ensure outpatient follow-up planned, and (4) see the patient tomorrow and follow closely. 218 
TDs rated their degree of comfort in managing the case as a dermatologist, as well as the quality 219 
of each image. 220 
Outcomes measured were concordance between the PD and the TDs for the following: primary 221 
diagnosis, primary diagnosis plus differential diagnosis, decision to biopsy, laboratory work-up, 222 
imaging, treatment, and follow-up plan. Primary outcomes were defined as primary plus 223 
differential diagnostic concordance as well as management plan concordance, the rational of 224 
which was to assess whether teledermatology could result in an appropriate work-up and 225 
management leading to an effective outcome for the patient. Secondary outcomes were primary 226 
diagnostic concordance alone, as well as concordance in work-up.  227 
Primary diagnostic concordance was defined as agreement between the primary diagnosis 228 
provided by the PD and the TD. Primary diagnostic plus differential diagnostic concordance was 229 
defined as the PD’s diagnosis being among the differential diagnosis of the TDs in cases when 230 
the primary diagnosis was discordant. The diagnoses themselves, and not diagnostic family, were 231 
used in calculating diagnostic concordance. 232 
Statistical Analysis 233 
We calculated the prevalence-adjusted bias-adjusted kappa (20) to quantify the concordance 234 
between a) the TDs’ and PD’s primary diagnosis, b) TDs’ primary diagnosis plus differential 235 
 diagnosis and PD’s primary diagnosis, and c) TDs’ and PD’s management plan (separately for 236 
each of the five domains: biopsy, work-up, imaging, treatment, and follow-up). The following 237 
criteria were used to assess significance: values ≤ 0 as indicating no agreement, 0.01–0.20 as 238 
none to slight, 0.21–0.40 as fair, 0.41– 0.60 as moderate, 0.61–0.80 as substantial, and 0.81–1.00 239 
as almost perfect agreement.(21) We evaluated the associations of the calculated concordance a) 240 
and b) with TDs’ years of experience and the reported photo quality rating, and the associations 241 
of the calculated concordance c) with photo quality using the Pearson correlation coefficient. We 242 
also evaluated the associations of TDs’ level of comfort managing patients (with photos and 243 
story alone) with photo quality and TDs’ years of experience using the Wilcoxon rank sum test. 244 
All were conducted using R version 3.6.1 (https://www.r-project.org/).  245 
RESULTS 246 
Table 1 depicts the characteristics of the patients included in the study surveys. The mean age 247 
was 54.1 years (standard deviation (SD) 23.7), 43.9% were female, 75.6% identified as 248 
Caucasian, and 68.3% as Non-Hispanic or Latino. The final diagnoses are provided that were 249 
used to evaluate diagnostic concordance. Diagnoses fell under a diverse set of diagnostic 250 
families, consisting of hypersensitivity reactions (29.3%), vascular (19.5%), infectious (17.1%), 251 
inflammatory (17.1%), neoplastic (7.3%), iatrogenic (4.9%) and traumatic (4.9%). 252 
The TDs were 40.7% female and practiced in diverse academic institutions from all geographic 253 
regions of the United States. The mean number of years’ experience of each of the TDs was 7.0 254 
(SD 1.2) (Table 2). Out of all cases, 45.1% of TDs felt comfortable managing the case as a 255 
teledermatologist. The mean number of differential diagnoses per TD per individual case was 2.6 256 
(SD 0.4). 257 
 There was fair concordance between PD and TD primary diagnosis alone (median concordance 258 
66.7%, interquartile range (IQR) 57.1% to 78.6%; median kappa=0.33, interquartile range (IQR) 259 
0.14 to 0.57), with substantial agreement between PD and TD primary plus differential diagnosis 260 
(median concordance 91.7%, IQR 85.7% to 92.9%; median kappa=0.83, IQR 0.71 to 0.86). 261 
There was substantial agreement in pursuing additional laboratory work-up (median concordance 262 
85.7%, IQR 85.7% to 92.9%; median kappa=0.67, IQR 0.43 to 0.79), and almost perfect 263 
agreement in imaging decisions (median concordance 100%, IQR 50.0% to 100.0%; kappa=1.0, 264 
IQR, 0.0-1.0). There was moderate agreement in the decision to biopsy (median concordance 265 
71.4%, IQR 53.6% to 85.7%; median kappa=0.43, IQR 0.07 to 0.71). There was almost perfect 266 
agreement in treatment plans (median concordance 100%, IQR 85.7% to 100.0%; median 267 
kappa=1.0, IQR 0.67 to 1.0). There was no agreement in the follow-up plan (median 268 
concordance 50.0%, IQR 42.9% to 66.7%; median kappa=0.0, IQR -0.14 to 0.14). Figure 2 is a 269 
pair of histograms depicting the distribution of kappa values for agreement between the TDs’ and 270 
the PD’s primary diagnosis (Figure 2A), and primary plus differential diagnosis (Figure 2B). 271 
There was no association between experience of the TD and primary plus differential diagnostic 272 
concordance (correlation=-0.27; 95% confidence interval (CI) -0.59 to 0.12, scatterplot in 273 
Supplemental Figure 2, corresponding Supplemental Table 1) or primary diagnostic concordance 274 
(correlation=-0.27; 95% CI, -0.59 to 0.12). There was also no association between years’ 275 
experience of the TD and decision to pursue laboratory evaluation (correlation=-0.19; 95% CI, -276 
0.53 to 0.21), biopsy (correlation=-0.32; 95% CI, -0.62 to 0.07), imaging (correlation=-0.19; 277 
95% CI, -0.53 to 0.21), treatment decisions (correlation=-0.18; 95% CI, -0.53 to 0.21), and 278 
follow-up planning (correlation=-0.06; 95% CI, -0.33 to 0.43). 279 
 There was no association between either raw photo quality and the primary plus differential 280 
diagnosis (correlation=0.008; 95% CI, -0.18-0.19), or primary diagnostic concordance alone 281 
(correlation=-0.07; 95% CI, -0.12-0.25). The Wilcoxon rank sum test of the TDs’ comfort with 282 
managing the case and years of experience indicated that TDs with fewer years of experience 283 
were more likely to feel comfortable managing the patients as a teledermatologist (p=0.04).  284 
DISCUSSION 285 
This study illustrates that store-and-forward teledermatology may be reliable in the academic 286 
inpatient setting, with strong agreement between PD and TD for diagnosis, work-up, and 287 
management.  288 
The high concordance of primary plus differential diagnosis is in-line with prior outpatient 289 
literature,(8, 22) with studies demonstrating diagnostic concordance ranging from 41% to 100% 290 
for store-and-forward cases.(2) This finding builds upon limited studies evaluating the use of 291 
teledermatology in the inpatient setting.(12, 23, 24) As with prior study,(2) diagnostic 292 
concordance improved when the differential diagnosis was taken into account.  293 
The decision by TDs to pursue work-up in this study was highly concordant, with substantial 294 
agreement in the laboratory work-up desired. However, there was only moderate agreement in 295 
the decision to biopsy, which is in contrast with a prior inpatient teledermatology study finding a 296 
>95% concordance in assessing need for biopsy.(12) This may be due to stylistic practice 297 
differences or individual comfort level. 298 
The treatment plans offered by the TDs were highly concordant with those of the PD, suggesting 299 
that the outcomes of each patient may have been the same if managed by teledermatology, even 300 
in cases where the primary diagnosis differed. This may be due to the high concordance of 301 
primary plus differential diagnosis, leading to treatment plans applicable to multiple diagnoses. 302 
 The baseline inter-dermatologist variability that occurs even with face-to-face consultations must 303 
also be taken into consideration, as a previous study of face-to-face, clinic-based dermatologists 304 
has found diagnostic testing to be 85% concordant, medical-based therapy to be 85% concordant, 305 
and clinic-based therapy 77% concordant, respectively.(22) Thus, some degree of discordance 306 
may be expected.  307 
The lack of concordance between TDs and the PD for follow-up plans suggests that in-person 308 
evaluation may be needed prior to disposition planning. Stylistic differences also likely played a 309 
role. Patient-specific factors may go into disposition planning, such as access to resources and 310 
health literacy, which may contribute to the discordance between the PD and the TDs. Further 311 
study of follow-up planning is needed to elucidate whether teledermatology may be reliable for 312 
this use. 313 
Photo quality was not associated with primary diagnostic concordance or primary plus 314 
differential diagnostic concordance. This suggests that even in cases in which image quality is 315 
suboptimal, the reliability of teledermatology may not be impacted. However, while the authors 316 
utilized images from heterogeneous sources, many photos utilized in the study surveys met the 317 
minimum standards recommended for teledermatology.(25) Additionally, assessment of image 318 
quality was not broken down into detailed components, such as lighting, focus, or capture of 319 
clinically-relevant information. Photo quality and training in obtaining photos may be needed to 320 
ensure good capture of the relevant areas when implementing teledermatology, as the study 321 
photos were captured by dermatology resident physicians.  322 
There was no association between experience of the teledermatologist and diagnostic 323 
concordance, illustrating the generalizability of teledermatology across all ages of practicing 324 
dermatologists.  325 
 There appeared to be a disconnect between concordance and the TDs’ level of comfort in 326 
managing each case as a teledermatologist. The TDs considered themselves comfortable less 327 
than half of the time; however, their survey responses often aligned with the PD. This may be in 328 
part due to the novelty of teledermatology. The TDs with fewer years of experience were more 329 
likely to feel comfortable managing the case, aligning with prior literature,(26) reflecting an 330 
opportunity to utilize teledermatology even in novice practice settings. Similarly, 331 
teledermatology exposure in residency may correlate with comfort of use,(27) suggesting that 332 
early incorporation of teledermatology in training may facilitate its implementation.  333 
One of the greatest strengths of this study is the large sample size of TDs, mimicking the 334 
heterogeneity of applying teledermatology to real-life practice settings. The distribution of 335 
diagnoses included in this study reflects that of common dermatology consultations.(13) 336 
Limitations of this study include its single-center nature and the fact that dermatology residents 337 
captured the clinical photos. The dermatology residents may have had a more thorough 338 
understanding of how to obtain a high-quality dermatology photo than non-dermatology staff, 339 
who would be submitting the teledermatology consult in real-life. Training of non-dermatology 340 
staff in obtaining high-quality images may be needed. On the other hand, camera technology has 341 
likely improved today and may lead to heightened quality of photos in today’s use of 342 
teledermatology. Further study is needed to determine best practices for implementing an 343 
inpatient teledermatology program.  344 
In conclusion, teledermatology may be effective for managing dermatologic disease in the 345 
inpatient setting and leads to highly concordant diagnostic, work-up, and management decisions 346 
when performed by experienced inpatient dermatologists. This may represent a novel and 347 
effective option for community hospitals and may be particularly applicable during times of 348 
 concern for spread of infectious disease, such as during the 2019-2020 outbreak of the severe 349 
acute respiratory syndrome coronavirus 2 (SARS-CoV-2). 350 
 351 
Table 1. Demographic characteristics of patients included in this study. 352 
Patient characteristic Total (n=41) 
Age in years, mean (SD) 54.1 (23.7) 
Sex, n (%) 
Female 
 
18 (43.9) 
Race, n (%) 
Asian 
Black or African American 
Caucasian 
Unknown 
Ethnicity 
Hispanic or Latino 
Not Hispanic or Latino 
Unknown 
 
2 (4.9) 
4 (9.8) 
31 (75.6) 
4 (9.8) 
 
0 (0.0) 
28 (68.3) 
13 (31.7) 
Dermatologic consultation characteristics 
 Chronology of skin findings, median (IQR) (days) 
 Medications, mean (SD) 
 
4.0 (2.0-14.0) 
7.0 (3.7) 
Final diagnostic categories 
 Hypersensitivity 
  Contact dermatitis (4) 
  Drug hypersensitivity (6) 
  Erythema nodosum 
  Urticaria  
 Vascular 
  Calciphylaxis 
  Henoch-Schonlein purpura 
  Leukocytoclastic vasculitis 
  Lipodermatosclerosis 
  Small vessel vasculitis 
  Stasis dermatitis (3) 
 Infectious  
  Atypical mycobacterial infection 
  Bullous impetigo 
  Eczema herpeticum 
  Herpes simplex virus 
  Erythema chronicum migrans (2) 
  Varicella zoster virus 
 Inflammatory 
  Atopic dermatitis 
  Gout 
 
12 (29.3) 
 
 
 
 
8 (19.5) 
 
 
 
 
 
 
7 (17.1) 
 
 
 
 
 
 
7 (17.1) 
 
 
   Granulomatous disease 
  Hiradenitis suppurativa 
  Miliaria rubra 
  Pyoderma gangrenosum (2) 
 Neoplastic  
  Carcinoma erysipeloides 
  Kaposi sarcoma 
  Nevus lipomatosus 
 Iatrogenic 
  Steroid acne 
  Warfarin skin necrosis 
 Traumatic 
  Bateman’s purpura 
  Neurotic excoriations 
 
 
 
 
3 (7.3) 
 
 
 
2 (4.9) 
 
 
2 (4.9) 
 353 
 354 
Table 2. Characteristics of the surveyed teledermatologists.  355 
Characteristic Total (n=27) 
Sex, n(%) 
 Female 
Geographic distribution 
 Northeast 
 Midwest 
 West 
 Southeast 
 Southwest 
Years of experience, mean (SD) 
 
 
11 (40.7) 
 
13 (48.2) 
5 (18.5) 
5 (18.5) 
3 (11.1) 
1 (3.7) 
7.0 (1.2) 
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 358 
 359 
 360 
 361 
 362 
 363 
 364 
 365 
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 FIGURE LEGENDS 445 
Figure 1. Selection criteria for cases to include in study.  446 
 447 
Figure 2. Distribution of Kappa values for agreement between the teledermatologists’ and the 448 
primary dermatologist’s (A) primary diagnosis and (B) primary plus differential diagnosis. 449 
 450 
SUPPLEMENTS 451 
Supplemental Figure 1. Sample case within a survey set provided to the teledermatologists. The 452 
original diagnosis provided by the primary dermatologist was an atypical mycobacterial 453 
infection.  454 
 455 
Supplemental Figure 2. Scatterplot of the correlation between the teledermatologists’ (TDs’) 456 
primary plus differential diagnosis and the primary dermatologist’s (PD’s) primary diagnosis. 457 
Each point represents a teledermatologist (TD), color-coded by which survey set the TD 458 
participated in. The absence of clustering of points by color and the wide variation in TDs’ years 459 
of experience indicate that TDs’ years of experience exhibit robust nonassociation with the 460 
concordance between the TD’s primary plus differential diagnosis and the primary dermatologist 461 
(PD)’s primary diagnosis.  462 
 463 
Supplemental Table 1. Tabular representation of the years’ experience of the teledermatologists 464 
(TDs) with corresponding kappa values for primary and primary plus differential diagnostic 465 
concordance. 466 
 467 
 468 
  469 


Capsule summary:  
 
- Inpatient access to dermatologists is limited, highlighting an opportunity to utilize 
teledermatology within the inpatient setting. 
-Teledermatology in the inpatient setting may be a clinically acceptable option for diagnosis, 
evaluation, and management. This may represent a novel and effective option for hospitals. 
 
